Clinical Trials Logo

Filter by:
NCT ID: NCT03530592 Not yet recruiting - Mobility Limitation Clinical Trials

Seated Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this research study is to test the utility of an ankle robot in people with ankle weakness and foot drop from a peripheral nervous system injury due to neuromuscular or orthopedic injury.

NCT ID: NCT03522558 Not yet recruiting - Malnutrition Clinical Trials

Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to compare standardized nutrition therapy provided by a registered dietitian (RD) at regularly scheduled intervals to usual care in terms of the ability to improve growth parameters in medically complex infants in the pediatric outpatient setting.

NCT ID: NCT03518333 Not yet recruiting - Clinical trials for Erectile Dysfunction

Evaluation of the Tissue Genesis Icellator Cell Isolation System to Treat Erectile Dysfunction

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This clinical study is designed to investigate the safety and potential ability of relocated autologous SVF (stromal vascular fraction) to restore erectile function in men with ED (erectile dysfunction).

NCT ID: NCT03506685 Not yet recruiting - Clinical trials for Pain and Anterior Cruciate Ligament Reconstruction

Effectiveness of Dry Needling and STM on Pain Management for ACLR

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if dry needling (DN) and soft tissue mobilization (STM) is superior to standard treatment protocol for affecting pain, pain medication usage and measurements of range of motion (ROM) after ACL reconstruction surgery compared to a standard treatment protocol. Measurements of pain, pain medication usage, lower extremity functional scale (LEFS) and ROM will be taken day 2 post op and 1 week, 2 weeks, 3 weeks, and 4 weeks post op. It is hypothesized that the inclusion of DN and STM will acutely decrease the demand for pain medication and improve objective measurements when compared to a standard treatment protocol. Findings will potentially lead to insights as to the benefit of applying these interventions to help decrease the demand for pain medication post-surgery.

NCT ID: NCT03494127 Not yet recruiting - Mobility Impairment Clinical Trials

User Evaluation of Advanced Personalized Modular Pressure Relief Seating Cushion Systems

Squishycushion
Start date: August 23, 2024
Phase: N/A
Study type: Interventional

30 Veterans who are full-time wheelchair users will use personalized modular cushions for two weeks each. Personalized cushions will be created using a cushion fitting process the investigators have already developed and tested. Microenvironmental conditions will be monitored during use. A cost analysis will ensure the customized modular cushion applies value-driven principles. User satisfaction will be measured along with the effects on daily function, skin status and seated tissue health.

NCT ID: NCT03491020 Not yet recruiting - Clinical trials for Pathogen Transmission

Emission Patterns of Respiratory Pathogens

Start date: July 2024
Phase:
Study type: Observational

Airborne transmission represents one of the most rapidly spreading and dangerous dissemination mechanisms for pathogens. Public health strategies to prevent and control the often explosive outbreaks associated with such pathogens are: 1) vaccination and treatment, if available, 2) isolation and barrier precautions such as face masks, and 3) decontamination of the exposed areas and surfaces. A lack of understanding how these pathogens are transmitted hampers the ability to develop effective prevention measures. This study will be used to collect preliminary data of the emission patterns of respiratory pathogens.

NCT ID: NCT03474718 Not yet recruiting - Androgenic Alopecia Clinical Trials

Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia

Start date: August 2024
Phase: Early Phase 1
Study type: Interventional

The study team will assess the efficacy of platelet-rich plasma therapy, a special blood product which is from the participant's own body, in the treatment of androgenic alopecia (also known as male pattern hair loss) in females.

NCT ID: NCT03473964 Not yet recruiting - Sarcoid Uveitis Clinical Trials

(ACTH) for the Treatment of Sarcoid Uveitis

ACTH
Start date: April 1, 2018
Phase:
Study type: Observational

Sarcoidosis is a multisystem granulomatous disease that can affect nearly any organ in the body. While most commonly affecting the lungs, vision threatening eye involvement occurs in approximately 25% of patients with sarcoid. Eye involvement may lead to a chronic, sight-threatening uveitis which may result in cataract, glaucoma, and macular edema. The treatment of sarcoid uveitis involves the use of topical and systemic corticosteroids or potent immunosuppressive agents (medications that suppress the body's immune system) both of which can cause severe long-term side effects. The adverse effects of steroids may be avoided by treatment with the use as H.P. Acthar® Gel. The effectiveness of H.P. Acthar® Gel in the treatment of sarcoid uveitis and patient quality of live have not been previously examined. These issues, will be explored in this research.

NCT ID: NCT03473769 Not yet recruiting - Sepsis Clinical Trials

Sepsis Pre-Alert Monitoring Intervention: Study to Investigate Targeted Enhanced Monitoring for Sepsis

Start date: September 1, 2024
Phase: N/A
Study type: Interventional

Sepsis is a leading cause of death worldwide, and contributes to approximately 750,000 hospitalizations per year, a third of which may die. International guidelines recommend timely interventions, including cultures, fluid resuscitation and antibiotics. Following guideline bundles is associated with a decrease in mortality. Key to timely intervention is timely diagnosis. Using the Epic sepsis predictive analytic tool, investigators will trigger vital sign and delirium monitoring in patients determined to be at increased risk for developing future sepsis. The primary objective of this study is to demonstrate reduced mortality in patients for whom the pre-sepsis algorithm threshold is met, and who enhanced monitoring.

NCT ID: NCT03470272 Not yet recruiting - Obesity Clinical Trials

Effects of Red Light LED Therapy on Body Contouring

Start date: September 30, 2018
Phase: N/A
Study type: Interventional

Red light laser therapy using 635nm red light laser technology has previously been shown to cause lipolysis in subcutaneous fat as a non-surgical method to promote weight loss and body contouring. This study hypothesizes that red LED light therapy using 650nm red light LED (light emitting diode) technology produces similar results to the laser device (red LASER 635nm) when preformed using a specified treatment protocol.